Autres langues SyntekaBio, Inc.

Actions

A226330

KR7226330009

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 14/05/2024			Varia. 5j.	Varia. 1 janv.
9 870 ^KRW	+2,39 %		-1,69 %	-30,69 %

07/05	Syntekabio annonce la présentation de sa plateforme de découverte de produits biologiques à PEGS Boston	CI
11/04	Syntekabio présentera ses technologies innovantes de découverte de médicaments par l'IA à Bio-IT World	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Syntekabio Announces to Showcase Biologics Discovery Platform At PEGS Boston	07/05
SyntekaBio, Inc. announced that it has received KRW 10 billion in funding from Korea Investment Partners Co. Ltd.	26/04
Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World	11/04
SyntekaBio, Inc. announced that it expects to receive KRW 10 billion in funding from Korea Investment Partners Co. Ltd.	28/03
Polarisqb and Syntekabio Sign MOU for Collaborative AI and Quantum-Pored Drug Development Service	31/08/23
SyntekaBio, Inc. announced that it has received KRW 10 billion in funding	28/07/23
SyntekaBio, Inc. announced that it expects to receive KRW 10 billion in funding	21/07/23
Syntekabio Announces the Launch of its Cost-Effective AI-Based Total Solution Service for Finding New Drug Candidates	03/06/23
SyntekaBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
Syntekabio, Inc. Launches STB Cloud Worldwide	16/12/22
Advanced AI Drug Development Platform 'DeepMatcher' 2.0 Launches Worldwide (226330.KQ)	22/09/22
Advanced AI Drug Development Platform 'DeepMatcher®' 2.0 Launches Worldwide (226330.KQ)	21/09/22
SyntekaBio, Inc. announced that it has received KRW 25 billion in funding from Shinhan Financial Investment Co., Ltd., Saneun Capital Co., Ltd., Best Investment & Securities Co., Ltd., IBK Capital Corporation,KDB Capital Corp., Shinhan Investment Corp., Investment Arm and other investors	30/11/21
SyntekaBio, Inc. announced that it expects to receive KRW 25 billion in funding from Shinhan Financial Investment Co., Ltd., Saneun Capital Co., Ltd., Best Investment & Securities Co., Ltd., IBK Capital Corporation, KDB Capital Corp., Shinhan Investment Corp., Investment Arm and other investors	25/11/21
SyntekaBio, Inc.(KOSDAQ:A226330) added to S&P Global BMI Index	21/09/20
Syntekabio Presents Nonclinical Data of Immuno-Oncologic Agent Stb-C017 At the 2020 AACR Meeting	15/05/20
SyntekaBio, Inc. has completed an IPO in the amount of KRW 19.2 billion.	12/12/19
Syntekabio Enters into Agreement with CHA Hospital	06/12/19
SyntekaBio, Inc. has filed an IPO.	26/08/19
Syntekabio, Inc. announced that it has received KRW 19.69994646 billion in funding from a group of investors	21/06/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SyntekaBio, Inc.

Actions

A226330

KR7226330009

Autres langues

Filtres